{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:29:53Z","timestamp":1791221393846,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jneuroim.2020.577313","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T02:13:23Z","timestamp":1593828803000},"page":"577313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis"],"prefix":"10.1016","volume":"346","author":[{"given":"Hossein","family":"Keyvani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Zahednasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussain ali abraham","family":"Aljanabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Esghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Karampoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577313_bb0005","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/135245859800400606","article-title":"Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report","volume":"4","author":"Ablashi","year":"1998","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00705-013-1902-5","article-title":"Classification of HHV-6A and HHV-6B as distinct viruses","volume":"159","author":"Ablashi","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/13550280591002379","article-title":"Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes","volume":"11","author":"Ahlqvist","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0020","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/archneur.61.10.1523","article-title":"Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection","volume":"61","author":"\u00c1lvarez-Lafuente","year":"2004","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577313_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bjid.2020.02.001","article-title":"Serum levels of matrix metalloproteinase-2,-9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity","volume":"24","author":"Amini","year":"2020","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0030","first-page":"183","article-title":"Role of IFN gamma on TNF alpha, IL-1 beta and IL-6 release during HHV-6 infection","volume":"19","author":"Arena","year":"1996","journal-title":"New Microbiol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0035","first-page":"13","article-title":"Productive HHV-6 infection in differentiated U937 cells: role of TNF alpha in regulation of HHV-6","volume":"20","author":"Arena","year":"1997","journal-title":"New Microbiol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13365-012-0138-6","article-title":"Prevalence of human herpesvirus U94\/REP antibodies and DNA in Tunisian multiple sclerosis patients","volume":"19","author":"Ben-Fredj","year":"2013","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-04432-y","article-title":"Expression of the human herpesvirus 6A latency-associated transcript U94A disrupts human oligodendrocyte progenitor migration","volume":"7","author":"Campbell","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0055","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jmv.10133","article-title":"HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines","volume":"67","author":"Caruso","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jmv.10416","article-title":"Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures","volume":"70","author":"Caruso","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0065","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/JCM.40.11.4131-4137.2002","article-title":"Detection of antibodies directed against human herpesvirus 6 U94\/REP in sera of patients affected by multiple sclerosis","volume":"40","author":"Caselli","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1086\/368166","article-title":"High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection","volume":"187","author":"Cermelli","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0075","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1073\/pnas.92.16.7440","article-title":"Plaque-associated expression of human herpesvirus 6 in multiple sclerosis","volume":"92","author":"Challoner","year":"1995","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jmv.10258","article-title":"Correlation between HHV-6 reactivation and multiple sclerosis disease activity","volume":"69","author":"Chapenko","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jmv.10190","article-title":"Human herpesvirus 6 and multiple sclerosis: a study of t cell cross-reactivity to viral and myelin basic protein antigens","volume":"68","author":"Cirone","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0090","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00415-005-0794-z","article-title":"Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B\u2013cell response","volume":"252","author":"Derfuss","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0095","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1128\/JVI.73.10.8040-8052.1999","article-title":"Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A","volume":"73","author":"Dominguez","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-12-107","article-title":"MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up","volume":"12","author":"Dominguez-Mozo","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0105","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3389\/fimmu.2019.02715","article-title":"Increased serological response against human herpesvirus 6A is associated with risk for multiple sclerosis","volume":"10","author":"Engdahl","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0110","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1128\/jvi.65.9.5105-5110.1991","article-title":"Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures","volume":"65","author":"Flamand","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0115","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1128\/jvi.67.11.6768-6777.1993","article-title":"Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6","volume":"67","author":"Flamand","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0120","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1172\/JCI118557","article-title":"Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15","volume":"97","author":"Flamand","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/135245859900500509","article-title":"The association of the human herpesvirus-6 and MS","volume":"5","author":"Friedman","year":"1999","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jns.2011.09.001","article-title":"Herpesvirus active replication in multiple sclerosis: a genetic control?","volume":"311","author":"Garcia-Montojo","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0135","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/nm1101-1232","article-title":"Suppression of CCR5-but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6","volume":"7","author":"Grivel","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0140","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1128\/JVI.77.15.8280-8289.2003","article-title":"Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo","volume":"77","author":"Grivel","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0145","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1073\/pnas.1105143108","article-title":"Human herpesvirus-6 entry into the central nervous system through the olfactory pathway","volume":"108","author":"Harberts","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2020.577313_bb0155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1128\/JCM.05834-11","article-title":"Development of a human herpesvirus 6 species-specific immunoblotting assay","volume":"50","author":"Higashimoto","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1084\/jem.170.2.607","article-title":"Tumor necrosis factor identified in multiple sclerosis brain","volume":"170","author":"Hofman","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1096-9071(199605)49:1<34::AID-JMV6>3.0.CO;2-L","article-title":"Human herpesvirus 6 induces IL-8 gene expression in human hepatoma cell line, Hep G2","volume":"49","author":"Inagi","year":"1996","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/13550280390241241","article-title":"Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death","volume":"9","author":"Kong","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0175","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4103\/1673-5374.194804","article-title":"Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response","volume":"11","author":"Koudriavtseva","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0180","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1352458507080063","article-title":"Human herpes virus 6 and multiple sclerosis: a Finnish twin study","volume":"14","author":"Kuusisto","year":"2008","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.coviro.2014.09.016","article-title":"Evidence linking HHV-6 with multiple sclerosis: an update","volume":"9","author":"Leibovitch","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1352458517737392","article-title":"Viruses in chronic progressive neurologic disease","volume":"24","author":"Leibovitch","year":"2018","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092328","article-title":"Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay","volume":"9","author":"Leibovitch","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2020.577313_bb0200","doi-asserted-by":"crossref","first-page":"11292","DOI":"10.1073\/pnas.1811974115","article-title":"Herpesvirus trigger accelerates neuroinflammation in a nonhuman primate model of multiple sclerosis","volume":"115","author":"Leibovitch","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/13550289509114021","article-title":"Human herpesvirus 6 polymerase chain reaction findings in human immunodeficiency virus associated neurological disease and multiple sclerosis","volume":"1","author":"Liedtke","year":"1995","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0210","first-page":"105","article-title":"Role of IL-15 on monocytic resistance to human herpesvirus 6 infection","volume":"23","author":"Mastroeni","year":"2000","journal-title":"Microbiologica"},{"key":"10.1016\/j.jneuroim.2020.577313_bb0215","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.1128\/JVI.75.23.11641-11650.2001","article-title":"Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms","volume":"75","author":"Mayne","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2005.03.013","article-title":"Modulation of the cytokine network in human adult astrocytes by human herpesvirus-6A","volume":"164","author":"Meeuwsen","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-0404.1997.tb08154.x","article-title":"Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis","volume":"95","author":"Nielsen","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/13550289909045382","article-title":"A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients","volume":"5","author":"Ongr\u00e1di","year":"1999","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0235","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/brain\/awh390","article-title":"Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter","volume":"128","author":"Opsahl","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2020.577313_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577069","article-title":"The protective effect of helicobacter pylori infection on the susceptibility of multiple sclerosis","volume":"337","author":"Ranjbar","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0245","article-title":"Human herpesvirus 6 and neuroinflammation","volume":"2013","author":"Reynaud","year":"2013","journal-title":"ISRN Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/13550289609146888","article-title":"Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction","volume":"2","author":"Sanders","year":"1996","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0255","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410230405","article-title":"Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro","volume":"23","author":"Selmaj","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0260","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0265","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2002-10-3152","article-title":"Selective suppression of IL-12 production by human herpesvirus 6","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2020.577313_bb0270","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/JVI.79.5.2807-2813.2005","article-title":"Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6","volume":"79","author":"Smith","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0275","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm1297-1394","article-title":"Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA","volume":"3","author":"Soldan","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0280","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2015.00520","article-title":"Infection as an environmental trigger of multiple sclerosis disease exacerbation","volume":"6","author":"Steelman","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0285","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/135502801753248150","article-title":"Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system","volume":"7","author":"Tomsone","year":"2001","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0290","series-title":"Seminars in Neurology","first-page":"307","author":"Tselis","year":"2011"},{"key":"10.1016\/j.jneuroim.2020.577313_bb0295","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000069461.53733.F7","article-title":"The immune response against herpesvirus is more prominent in the early stages of MS","volume":"60","author":"Villoslada","year":"2003","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0300","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/13550280701381332","article-title":"Evidence for human herpesvirus 6 variant a antibodies in multiple sclerosis: diagnostic and therapeutic implications","volume":"13","author":"Virtanen","year":"2007","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0305","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-5728(94)90198-8","article-title":"A potential role for human herpesvirus type 6 in nervous system disease","volume":"49","author":"Wilborn","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577313_bb0310","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jmv.2158","article-title":"HHV-6 A-or B-specific P41 antigens do not reveal virus variant-specific IgG or IgM responses in human serum","volume":"66","author":"Xu","year":"2002","journal-title":"J. Med. Virol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820301697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820301697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:37:37Z","timestamp":1759048657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820301697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":62,"alternative-id":["S0165572820301697"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577313","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577313"}}